Skip to main content
. 2023 Feb 12;12(8):9351–9362. doi: 10.1002/cam4.5692

FIGURE 2.

FIGURE 2

Probability of csPCa before and after partial gland ablation (PGA). Chart showing chances of csPCa on MRI‐guided biopsy (MRGB) before and after partial gland ablation (PGA) with cryotherapy. At baseline (time zero), all 136 patients had csPCa, either GG2 (open boxes, N = 93, including 5 with high‐volume GG1) or GG>3 (dark boxes, N = 43). Biopsy evidence of csPCa was found at 6 months in 22% of men whose pretreatment cancer was GG2 and in 30% of men whose cancer was >GG3. Among men with pretreatment cancer of GG3, 30% were found to have csPCa at 6 months and 43% at 18 months. Chances of a successful ablation, defined as absence of csPCa on MRGB, decreased somewhat over time, but were not significantly different between GG2 and GG3 groups. Overlap of the 95% C.I. is appreciable at both follow‐up intervals.